baber/WOPTO huggingface dataset:
Patent EP-4002887-A1 (EP)
Inventor: ANTONSEN FRANK
IPC: H04R25/00
Filed: 2021-11-04
Abstract: The disclosure relates to a battery charger for one or more hearing devices, comprising: a test sound generator configured to produce testing sound; an input configured to obtain first information regarding a first microphone output of a first hearing device in response to the testing sound and obtain second information regarding a second microphone output in response to the testing sound. A processing unit is configured to detect a clogging of a filter such as a wax filter based at least in part on the first information regarding the first microphone output of the first hearing device, and based at least in part on the second information regarding the second microphone output. An output is configured to provide a signal indicating the clogging of the filter.
Patent EP-4001474-A1 (EP)
Title: Hybrid sealing for anodized metal
Inventor: CHEN LEI
IPC: C25D11/24
Filed: 2021-11-05
Abstract: Disclosed is a method of providing corrosion protection to an anodized metal including providing a metal having an anodization layer wherein the anodization layer includes a barrier portion; contacting the anodization layer with a first solution at a first temperature to seal the barrier portion; and contacting the anodization layer with the sealed barrier portion with a second solution at a second temperature to deposit a precipitated rare earth compound in the anodization layer with the sealed barrier portion; wherein the first solution includes a transition metal oxyanion and has a pH of 3 to 6 and the second solution includes a trivalent rare earth cation.
Patent EP-3988635-A1 (EP)
Title: Heavy duty laundry detergent
Inventor: BRITTON CLAUDIA
IPC: C11D3/48
Filed: 2016-04-20
Abstract: A laundry detergent formulation is provided that is formed as an aqueous blend of surfactants, enzymes, builders and soil release polymers to inhibit soil re-deposition back onto other clothing or elements of the washing machine. The detergent formulation also contains additives with properties that impart a treatment to fabrics that inhibits future soil deposition onto the clothing with continued use. The detergent formulation provides cleaning of heavy duty grease and automotive soils from clothing surfaces that is superior to current detergent products.
Patent EP-4197633-A1 (EP)
Inventor: SCHNEIDER CAROLIN
IPC: B01J31/02
Filed: 2021-12-17
Abstract: Pt-Komplex-Gemisch, sowie dessen Einsatz in der Katalyse.
Patent EP-4194932-A1 (EP)
Inventor: JALLOULI AREF
IPC: G02C7/02
Filed: 2021-12-10
Abstract: The present disclosure relates to ophthalmic lenses for correction of myopia. In particular, the present disclosure relates to an ophthalmic lens, comprising a first layer having microstructures on a first surface of the first layer, the microstructures on the first surface of the first layer being formed in a pattern, a material of the first layer being a thermoplastic material; and a second layer formed on the first surface of the first layer, wherein a glass transition temperature of the first layer is higher than a glass transition temperature of the second layer.
Patent EP-4198615-A1 (EP)
Title: Method for determining an ophthalmic lens
Inventor: SPIEGEL DANIEL
IPC: G02C7/02
Filed: 2021-12-16
Abstract: The invention relates to a method for determining an ophthalmic lens for a wearer and suitable for correcting the wearer's vision, comprising c) determining a virtual lens by an optimization process involving calculating iteratively a surface of the virtual lens so as to match target optical characteristics of a target lens, checking whether peripheral defocus values of the virtual lens satisfy a predetermined criterion, and if the predetermined criterion is not satisfied, reiterating the calculation of the surface of the virtual lens after modifying the target lens of the previous iteration. The determined ophthalmic lens is defined as being the virtual lens at the end of the optimization process. 
     The invention also relates to an ophthalmic lens for a wearer for correcting the wearer's vision and intended to reduce peripheral defocus.
Patent EP-3883806-A1 (EP)
Inventor: VANLUCHENE YVAN
IPC: B60K35/00
Filed: 2021-01-13
Abstract: The skin (1) comprises at least a translucent elastomeric layer (5) composed of a pigmented plastic material and comprising at least one first portion (8) which is configured to be placed in front of a light source (9). The light of this light source (9) produces an image on this first portion (8) of the translucent layer due to the presence of a surface relief (17, 18) on the surface of the translucent layer (5). A clearly visible image can be obtained by providing even small differences in thickness of the translucent layer (5) when the pigmented plastic material thereof has an average spectral attenuation coefficient (αav) of between 1.0 and 25 mm-1. The difference in layer thickness (d2-d1) and the average spectral attenuation coefficient (αav) should moreover be large enough to meet the formula: α av (d 2 - d 1 ) > -In a, wherein a is equal to 0.50. Since the surface relief (17, 18) can automatically be produced when moulding the translucent layer (5) against a mould surface, the image can easily be obtained in the correct position on the skin (1).
Patent EP-4088116-A1 (EP)
Inventor: DUPONT GUILHEM
IPC: G01N33/564
Filed: 2021-01-08
Abstract: La présente invention concerne des procédés permettant de fournir l'état pathologique d'un sujet, comprenant les étapes consistant à déterminer au moins deux paramètres représentant l'état d'une maladie du sujet à un premier instant ; à combiner les paramètres déterminés pour obtenir une signature représentant l'état pathologique au premier instant ; à répéter les étapes précédentes pour obtenir au moins une autre signature à un instant ultérieur ; et à combiner les signatures obtenues à l'étape précédente pour fournir un marqueur de progression indiquant l'état pathologique du sujet. L'invention concerne en outre une composition pharmaceutique destinée à être utilisée pour le traitement d'une maladie du système nerveux central (SNC). L'invention concerne également un dispositif mobile exécutant les procédés selon l'invention.
Patent EP-4090376-A1 (EP)
Inventor: VAN DELFT FLORIS LOUIS
IPC: A61P35/00
Filed: 2021-01-13
Abstract: The present invention provides antibody-payload conjugates having a payload-to-antibody ratio of 1. The antibody-payload conjugate having structure (1): Formula (1) wherein: - a, b and c are each independently 0 or 1; - L1, L2 and L3 are linkers; - D is a payload; - BM is a branching moiety; - Z are connecting groups obtainable by a cycloaddition reaction. The invention further provides a method for preparing the antibody-payload conjugate according to the invention, an intermediate compound in that preparation method, and medical uses of the antibody-payload conjugate according to the invention.
Patent EP-4111794-A1 (EP)
Title: Prioritization techniques between communication links
Inventor: DAMNJANOVIC JELENA
IPC: H04W72/12
Filed: 2021-01-21
Abstract: Methods, systems, and devices for wireless communications are described. A first user equipment (UE) may be scheduled for communicating a first message over a first communication link with a base station and a second message over second communication link with a second UE. The first UE may select to communicate using the first communication link or the second communication link based on one or more prioritization rules that may involve the priority of the first message and the second message. The first UE may identify a mapping between the priority of the first message and the priority of the second message that may enable a comparison of the priorities of the first message and the second message. The first UE may select to communicate using the communication link of the message associated with the higher priority.
Patent EP-4103270-A1 (EP)
Inventor: ENGLISH JAMES M
IPC: A61N1/365
Filed: 2021-02-12
Abstract: Embodiments of the present disclosure relate to implantable medical devices (IMDs). In an exemplary embodiment, an IMD comprises: a housing including a plurality of feedthroughs extending through the housing, a first electrode, a second electrode, and a biocompatible circuit board disposed around an outer surface of the housing. The biocompatible circuit board comprising a plurality of traces, wherein a first trace of the plurality of traces is coupled to the first electrode and a first feedthrough of the plurality of feedthroughs, and a second trace of the plurality of traces is coupled to the first electrode and a second feedthrough of the plurality of feedthroughs.
Patent EP-4107018-A1 (EP)
Inventor: MULVANE CURTIS
IPC: B63J2/04
Filed: 2021-02-18
Abstract: A windshield vent (10) includes a housing plate (12) with a vent opening (14) securable to a windshield (WS). A vent flap (16) secured in the opening is rotatable on an axle secured by clamps (18) between a closed position and an open position. The vent system is suitable for laminated glass windshields including a recess in which the housing plate is bonded.
Patent EP-4110416-A1 (EP)
Inventor: LYDECKER LAUREN
IPC: A61M1/00
Filed: 2021-02-19
Abstract: Un système médical comprend une source d'un matériau, un premier tube et un second tube. Le matériau est configuré pour se dilater et former un corps poreux après que le matériau est déployé dans une lumière corporelle. Le premier tube est configuré pour distribuer le matériau dans la lumière corporelle, et le second tube est configuré pour appliquer une aspiration au corps poreux.
Patent EP-4214797-A1 (EP)
Inventor: MICOVIC MIROSLAV
IPC: H01Q1/02
Filed: 2021-02-23
Abstract: Des procédés et un appareil pour fournir un bloc de sous-réseau d'éléments d'antenne N x M rectangulaire ayant des première et seconde surfaces principales opposées et des première et seconde extrémités aux extrémités opposées du bloc, les éléments d'antenne se trouvant à la première extrémité du bloc. Une plaque froide entre le premier raccord d'entrée et le premier raccord de sortie permet l'écoulement du liquide de refroidissement depuis le premier raccord d'entrée vers le premier raccord de sortie. Le premier raccord d'entrée est conçu pour permettre l'écoulement du liquide de refroidissement dans le système dans une direction qui est normale à la première surface principale du bloc.
Patent EP-4197029-A1 (EP)
Inventor: BRUGGER MICHAEL
IPC: H01L21/67
Filed: 2021-04-07
Abstract: Apparatus for processing a wafer-shaped article, the apparatus comprising a support configured to support the wafer-shaped article during a processing operation; wherein: the support comprises a support body and a plurality of gripping pin assemblies adapted and positioned relative to the support body for gripping the wafer-shaped article, wherein each of the gripping pin assemblies is rotatable relative to the support body between a gripping configuration in which the gripping pin assemblies grip the wafer-shaped article, and a non- gripping configuration in which the gripping pin assemblies do not grip the wafer-shaped article; each of the gripping pin assemblies protrudes from a respective hole in the support body; and a sealing member is positioned between at least one of the gripping pin assemblies and the respective hole, the sealing member being configured to restrict infiltration of a processing liquid used in the processing operation into the hole.
Patent EP-4135918-A1 (EP)
Inventor: KOOIJERS THEODORUS JOHANNES
IPC: B22C9/02
Filed: 2021-04-13
Abstract: Die Erfindung betrifft ein Verfahren zum schichtweisen Aufbau von ausgehärteten dreidimensional geschichteten Formkörpern für Gießereikerne und -formen aus einem feuerfesten Formgrundstoff (1) mit einer mittleren Korngröße im Bereich von 0,1 mm bis 2,0 mm und die Verwendung eines anorganischen Binders (3) enthaltend eine Alkalisilikatlösung zur Herstellung von ausgehärteten dreidimensional geschichteten Formkörpern für Gießereikerne und -formen.
Patent EP-4175703-A1 (EP)
Title: Atemwegstherapiegerät
Inventor: EBINGER ANDREA
IPC: A61M16/00
Filed: 2021-05-03
Abstract: Bei einem Atemwegstherapiegerät (1) zur Behandlung der Muskulatur von Atemwegen, Lungenfunktionen und/oder Schleimablagerungen im Lungen-, Nasen- und/oder Rachenraum eines Patienten (2), bestehend aus einem Hohlkörper (3), in dem mindestens ein Durchgangskanal (4, 5) vorgesehen ist, einem in den Hohlkörper (3) eingesetzten Mund- oder Nasenstück (6), das mit dem Patienten (2) während der Behandlungsdauer des Atemwegstherapiegerätes (1) verbunden ist, und aus mindestens einem im Inneren des Hohlkörpers (3) angeordneten Schwingkörper (11, 12), der durch die Ein- und/oder Ausatmung des Patienten (2) in eine oszillierende Vibration versetzt ist, eine oszillierende, resistive und/oder threshold typische Luftdruckschwingungen entstehen, bei denen die individuellen Widerstände bei der Ein- und Ausatmung individuell patientengerecht einstellbar ist und eine Umrüstung oder Umstellung des Atemwegstherapiegerätes (1) soll nicht erforderlich sein. Dies ist dadurch gelöst, dass in den Hohlkörper (3) ein Haltekörper (13) eingesetzt ist, in den mindestens eine Öffnung (14) eingearbeitet ist, dass an dem Haltekörper (13) im Bereich der Öffnung (14) eine frei schwingende Zunge (15) befestigt ist, durch die die Öffnung (14) des Haltekörpers (13) in Abhängigkeit von den im Inneren des Hohlkörpers (3) vorherrschenden Luftströmungen (7, 8) verschlossen oder bereichsweise freigegeben ist, dass die dem Mundstück (6) gegenüberliegende Stirnseite (9) des Hohlkörpers (3) offen ist, dass in diese Stirnseite (9) eine Stenose (18) eingesetzt ist, in deren Mantelfläche (19) mindestens zwei Durchgangsöffnungen (20) vorgesehen sind, durch die Luftströmungen (7, 8) in das Innere des Hohlkörpers (3) strömen oder vice versa austreten, dass die Durchgangsöffnungen (20) der Stenose (18) unterschiedliche Querschnittsflächen als Luftdurchlässe für die Luftströmungen (7, 8) aufweisen und dass die Stenose (18) in dem Hohlkörper (3) drehbar gelagert ist, derart dass durch Verdrehen der Stenose (18) eine der Durchgangsöffnungen (20) als Luftdurchlass auswählbar bzw. einstellbar ist.
Patent EP-4157291-A1 (EP)
Title: Ophthalmic composition based on hyaluronic acid to protect from damages caused by environmental pollution
Inventor: PORCHETTI ANNA
IPC: A61K47/00
Filed: 2021-05-19
Abstract: MNT003PAT-WO AL & Partners Srl - 9 - ABSTRACT The use of an ophthalmic composition consisting of hyaluronic acid or a physiologically acceptable salt thereof, preferably sodium salt, in admixture with excipients for ophthalmic use to protect the eyes from damages caused by environmental pollution, particularly by excessive exposure to blue light, is 5 disclosed.
Patent EP-4165533-A1 (EP)
Inventor: SHARMA NARESH KUMAR
IPC: G06F21/55
Filed: 2021-05-17
Abstract: Methods and systems for allowing software components that operate at a specific exception level (e.g., EL-3 to EL-1, etc.) to repeatedly or continuously observe or evaluate the integrity of software components operating at a lower exception level (e.g., EL-2 to EL-0) to ensure that the software components have not been corrupted or compromised (e.g., subjected to malware, cyberattacks, etc.) include a computing device that identifies, by a component operating at a higher exception level ("HEL component"), at least one of a current vector base address (VBA), an exception raising instruction (ERI) address, or a control and system register value associated with a component operating at a lower exception level ("LEL component"). The computing device may perform a responsive action in response to determining that the current VBA, the ERI address, or control and system register value do not match the corresponding reference data.
Patent EP-4162441-A1 (EP)
Inventor: BOUYSSOUX ALEXANDRE
IPC: G06T5/50
Filed: 2021-06-04
Abstract: The present invention relates to a method (M) for generating a color-faithful EDF, i.e. extended depth-of-field, image from a color volume (1), wherein the voxels for a fixed index going from 1 to L are 2D images acquired at different focal depths in a z-direction using a microscope, said method comprising the steps of: generating a grayscale volume (2); applying (M10) an invertible color-to-grayscale transformation to said volume (1); applying (M20) a wavelet transform to the grayscale volume (2) to obtain a 3D wavelet coefficient matrix (3); selecting wavelet coefficients using a predefined coefficient selection rule; generating (M40) a 2D wavelet coefficient matrix WCM and a 2D coefficient map CM; applying (M50) an inverse transformation of the wavelet transform to the 2D wavelet coefficient matrix WCM so as to obtain a 2D grayscale EDF image (4); generating a 2D color composite image CC; applying (M70) an inverse transformation of the color-to-grayscale transformation to the 2D grayscale EDF image (4) to obtain a 2D color EDF image (5); converting (M80) the 2D color composite image CC and the 2D color EDF image (5) into a color space comprising at least one chromaticity component and at least one intensity component; and concatenating (M90), the at least one chromaticity component of the 2D color composite image CC and the at least one intensity component of the 2D color EDF image (5), to obtain a color-faithful extended depth-of-field image.
Patent EP-4169149-A1 (EP)
Inventor: HODEBOURG GREGORY
IPC: H02K5/22
Filed: 2021-06-23
Abstract: Disclosed is a connector (52) suitable for equipping an assembly (1) comprising: - a rotating electrical machine (10) having an internal space comprising output pins (55) of the electrical machine, - an electronic module (5) having an internal space and comprising a plurality of input pins (56), characterised in that the connector (52) comprises: - an intermediate power connection system (60) suitable for connecting the output pins to the input pins, and - a closing piece (80) suitable for closing the internal space of the electrical machine and suitable for closing the internal space of the electronic module, the closing piece (80) being traversed by the intermediate power connection system (60).
Patent EP-4171616-A1 (EP)
Inventor: POLTORAK MATEUSZ PAWEL
IPC: A61K35/17
Filed: 2021-06-25
Abstract: Provided are engineered T cells that contain a modified T cell stimulation-associated locus encoding a recombinant receptor or a portion thereof. In some aspects, the nucleic acid sequence encoding the recombinant receptor or a portion thereof is operably linked to an endogenous transcriptional regulatory element of the T cell stimulation-associated locus, in some cases, engineered by targeted integration. In some aspects, the engineered cells conditionally express the recombinant receptor, such as upon stimulation or activation signal in the T cell. Also disclosed are cell compositions, nucleic acids for engineering cells, and methods and articles of manufacture for producing the engineered cells. In some embodiments, the engineered cells can be used in connection with cell therapy, including in connection with cancer immunotherapy comprising adoptive transfer of the engineered cells.
Patent EP-4208799-A1 (EP)
Inventor: ZHONG GUANWEN
IPC: G06F15/78
Filed: 2021-06-25
Abstract: Examples herein describe a programmable traffic management engine that includes both programmable and non-programmable hardware components. The non-programmable hardware components are used to generate features that can then be used to perform different traffic management algorithms. Depending on which traffic management algorithm the PTM engine is configured to do, the PTM engine may use a subset (or all) of the features to perform the algorithm. The programmable hardware components in the PTM engine are programmable (e.g., customizable) by the user to perform a selected algorithm using some or all of the features provided by the non-programmable hardware components.
Patent EP-3999594-A1 (EP)
Inventor: PLÖGER KURT
IPC: C09D5/16
Filed: 2021-07-19
Abstract: L'invention concerne un système de revêtement à trois composants pour la garniture intérieure d'un bateau. Un premier composant contient des polyesters insaturés en tant que liants et un agent ignifuge choisi parmi l'alkylester d'acide halogénophtalique, l'alkylester d'acide halogénobenzoïque et leurs mélanges. Le deuxième composant sert de durcisseur et contient du peroxyde organique et un solvant organique. Le troisième composant est une solution de composés cobalt organiques.
Patent EP-4087303-A1 (EP)
Title: Communication method and device
Inventor: XU XIAOYING
IPC: H04W24/02
Filed: 2021-01-18
Abstract: This application discloses a communication method and apparatus. The method includes: A second communication apparatus establishes at least one tunnel for a first radio bearer, where the at least one tunnel includes a first tunnel. The second communication apparatus sends a first message to a first communication apparatus, where the first message is carried in the first tunnel, the first message includes radio quality information of each of M logical channels, and the M logical channels are associated with the first radio bearer, where M is an integer greater than or equal to 1. According to the method, the second communication apparatus may send logical channel-level radio quality information to the first communication apparatus, so that the first communication apparatus can optimize data transmission more effectively based on the logical channel-level radio quality information.
Patent EP-4185611-A1 (EP)
Inventor: CHUNG SHAN-HUA
IPC: C07K16/40
Filed: 2021-07-22
Abstract: Herein is reported a method for producing an antibody-multimer-fusion polypeptide comprising (a) an antibody heavy chain and an antibody light chain, and (b) a first fusion polypeptide comprising in N- to C-terminal direction a first part of a non-antibody multimeric polypeptide, an antibody heavy chain CH1 domain or an antibody light chain constant domain, an antibody hinge region, an antibody heavy chain CH2 domain and an antibody heavy chain CH3 domain, and a second fusion polypeptide comprising in N- to C-terminal direction the second part of the non- antibody multimeric polypeptide and an antibody light chain constant domain if the first polypeptide comprises an antibody heavy chain CH1 domain or an antibody heavy chain CH1 domain if the first polypeptide comprises an antibody light chain constant domain, wherein (i) the antibody heavy chain of (a) and the first fusion polypeptide of (b), (ii) the antibody heavy chain of (a) and the antibody light chain of (a), and (iii) the first fusion polypeptide of (b) and the second fusion polypeptide of (b) are each independently of each other covalently linked to each other by at least one disulfide bond, characterized in that the antibody-multimer-fusion is expressed by a recombinant mammalian cell obtained by transfecting a mammalian cell with the expression cassettes for the antibody heavy chain, the antibody light chain, the first fusion polypeptide and the second fusion polypeptide at a stoichiometric ratio of 1:1:2:1.
Patent EP-4211321-A1 (EP)
Inventor: PADOVAN ENRICO
IPC: E04C2/32
Filed: 2021-08-30
Abstract: The invention is a composite panel (10) comprising two plane rectangular sheets (1, 2) made from metal plate and one intermediate corrugated rectangular sheet (3) made from metal plate which is interposed and constrained between said two plane sheets (1, 2), wherein said intermediate sheet (3) comprises a plurality of ridges (31) and depressions (32) which are rectilinear and parallel to one another, and wherein said ridges (31) and depressions (32) are oriented in such a way that they are oblique with respect to the edges (11, 12, 13, 14) of said panel (10).